High‐dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: A case series
Gespeichert in:
| Veröffentlicht in: | American journal of hematology 2003-08, Vol.73 (4), p.295-296 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 296 |
|---|---|
| container_issue | 4 |
| container_start_page | 295 |
| container_title | American journal of hematology |
| container_volume | 73 |
| creator | Talbot, Jeffrey Rizzieri, David A. DeCastro, Carlos M. Moore, Joseph O. Buckley, Patrick Laney, Rhonda Stevenson, Diane Brumbaugh, Heather Gockerman, Jon P. |
| description | |
| doi_str_mv | 10.1002/ajh.10362 |
| format | Article |
| fullrecord | <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_ajh_10362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AJH10362</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3562-15f55d7c4aeb56768532698e44589d69a4809d416cf4b2608313785d89c599953</originalsourceid><addsrcrecordid>eNp1kL1OwzAURi0EoqUw8ALIK0PATmLXZqsqoKBKLDBHrn1DXJI6slNV2XgEnpEnwSWVmJjuj44-3XsQuqTkhhKS3qp1FZuMp0doTInkieAsPUbjuKKxJ3KEzkJYE0JpLsgpGtFUTGWeiTFqFva9-v78Mi4A1r2uXVu50FaqsQaw2hgMnWtd2E-l87hVnYVNF_DOdhX2UHqlO-d7rPS2A9z0UDtrcA3bD2isusMzrFWMDuAthHN0Uqo6wMWhTtDbw_3rfJEsXx6f5rNlojPG04SykjEz1bmCFeNTLliWcikgz5mQhksVv5Amp1yX-SrlRGQ0mwpmhNRMSsmyCboecrV3IcQri9bbRvm-oKTYKyuisuJXWWSvBrbdrhowf-TBUQRuB2Bna-j_Typmz4sh8geov3ae</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>High‐dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: A case series</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Talbot, Jeffrey ; Rizzieri, David A. ; DeCastro, Carlos M. ; Moore, Joseph O. ; Buckley, Patrick ; Laney, Rhonda ; Stevenson, Diane ; Brumbaugh, Heather ; Gockerman, Jon P.</creator><creatorcontrib>Talbot, Jeffrey ; Rizzieri, David A. ; DeCastro, Carlos M. ; Moore, Joseph O. ; Buckley, Patrick ; Laney, Rhonda ; Stevenson, Diane ; Brumbaugh, Heather ; Gockerman, Jon P.</creatorcontrib><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.10362</identifier><identifier>PMID: 12879438</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Acute Disease ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols - administration & dosage ; Antineoplastic Combined Chemotherapy Protocols - toxicity ; Cyclophosphamide - administration & dosage ; Cyclophosphamide - toxicity ; Drug Evaluation ; Etoposide - administration & dosage ; Etoposide - toxicity ; Female ; Humans ; Leukemia, Myeloid - complications ; Leukemia, Myeloid - drug therapy ; Male ; Middle Aged ; Salvage Therapy ; Treatment Outcome</subject><ispartof>American journal of hematology, 2003-08, Vol.73 (4), p.295-296</ispartof><rights>Copyright © 2003 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3562-15f55d7c4aeb56768532698e44589d69a4809d416cf4b2608313785d89c599953</citedby><cites>FETCH-LOGICAL-c3562-15f55d7c4aeb56768532698e44589d69a4809d416cf4b2608313785d89c599953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.10362$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.10362$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12879438$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Talbot, Jeffrey</creatorcontrib><creatorcontrib>Rizzieri, David A.</creatorcontrib><creatorcontrib>DeCastro, Carlos M.</creatorcontrib><creatorcontrib>Moore, Joseph O.</creatorcontrib><creatorcontrib>Buckley, Patrick</creatorcontrib><creatorcontrib>Laney, Rhonda</creatorcontrib><creatorcontrib>Stevenson, Diane</creatorcontrib><creatorcontrib>Brumbaugh, Heather</creatorcontrib><creatorcontrib>Gockerman, Jon P.</creatorcontrib><title>High‐dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: A case series</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><subject>Acute Disease</subject><subject>Adult</subject><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - administration & dosage</subject><subject>Antineoplastic Combined Chemotherapy Protocols - toxicity</subject><subject>Cyclophosphamide - administration & dosage</subject><subject>Cyclophosphamide - toxicity</subject><subject>Drug Evaluation</subject><subject>Etoposide - administration & dosage</subject><subject>Etoposide - toxicity</subject><subject>Female</subject><subject>Humans</subject><subject>Leukemia, Myeloid - complications</subject><subject>Leukemia, Myeloid - drug therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Salvage Therapy</subject><subject>Treatment Outcome</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kL1OwzAURi0EoqUw8ALIK0PATmLXZqsqoKBKLDBHrn1DXJI6slNV2XgEnpEnwSWVmJjuj44-3XsQuqTkhhKS3qp1FZuMp0doTInkieAsPUbjuKKxJ3KEzkJYE0JpLsgpGtFUTGWeiTFqFva9-v78Mi4A1r2uXVu50FaqsQaw2hgMnWtd2E-l87hVnYVNF_DOdhX2UHqlO-d7rPS2A9z0UDtrcA3bD2isusMzrFWMDuAthHN0Uqo6wMWhTtDbw_3rfJEsXx6f5rNlojPG04SykjEz1bmCFeNTLliWcikgz5mQhksVv5Amp1yX-SrlRGQ0mwpmhNRMSsmyCboecrV3IcQri9bbRvm-oKTYKyuisuJXWWSvBrbdrhowf-TBUQRuB2Bna-j_Typmz4sh8geov3ae</recordid><startdate>200308</startdate><enddate>200308</enddate><creator>Talbot, Jeffrey</creator><creator>Rizzieri, David A.</creator><creator>DeCastro, Carlos M.</creator><creator>Moore, Joseph O.</creator><creator>Buckley, Patrick</creator><creator>Laney, Rhonda</creator><creator>Stevenson, Diane</creator><creator>Brumbaugh, Heather</creator><creator>Gockerman, Jon P.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200308</creationdate><title>High‐dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: A case series</title><author>Talbot, Jeffrey ; Rizzieri, David A. ; DeCastro, Carlos M. ; Moore, Joseph O. ; Buckley, Patrick ; Laney, Rhonda ; Stevenson, Diane ; Brumbaugh, Heather ; Gockerman, Jon P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3562-15f55d7c4aeb56768532698e44589d69a4809d416cf4b2608313785d89c599953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Acute Disease</topic><topic>Adult</topic><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - administration & dosage</topic><topic>Antineoplastic Combined Chemotherapy Protocols - toxicity</topic><topic>Cyclophosphamide - administration & dosage</topic><topic>Cyclophosphamide - toxicity</topic><topic>Drug Evaluation</topic><topic>Etoposide - administration & dosage</topic><topic>Etoposide - toxicity</topic><topic>Female</topic><topic>Humans</topic><topic>Leukemia, Myeloid - complications</topic><topic>Leukemia, Myeloid - drug therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Salvage Therapy</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Talbot, Jeffrey</creatorcontrib><creatorcontrib>Rizzieri, David A.</creatorcontrib><creatorcontrib>DeCastro, Carlos M.</creatorcontrib><creatorcontrib>Moore, Joseph O.</creatorcontrib><creatorcontrib>Buckley, Patrick</creatorcontrib><creatorcontrib>Laney, Rhonda</creatorcontrib><creatorcontrib>Stevenson, Diane</creatorcontrib><creatorcontrib>Brumbaugh, Heather</creatorcontrib><creatorcontrib>Gockerman, Jon P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Talbot, Jeffrey</au><au>Rizzieri, David A.</au><au>DeCastro, Carlos M.</au><au>Moore, Joseph O.</au><au>Buckley, Patrick</au><au>Laney, Rhonda</au><au>Stevenson, Diane</au><au>Brumbaugh, Heather</au><au>Gockerman, Jon P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High‐dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: A case series</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>2003-08</date><risdate>2003</risdate><volume>73</volume><issue>4</issue><spage>295</spage><epage>296</epage><pages>295-296</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>12879438</pmid><doi>10.1002/ajh.10362</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0361-8609 |
| ispartof | American journal of hematology, 2003-08, Vol.73 (4), p.295-296 |
| issn | 0361-8609 1096-8652 |
| language | eng |
| recordid | cdi_crossref_primary_10_1002_ajh_10362 |
| source | Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals |
| subjects | Acute Disease Adult Aged Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - toxicity Cyclophosphamide - administration & dosage Cyclophosphamide - toxicity Drug Evaluation Etoposide - administration & dosage Etoposide - toxicity Female Humans Leukemia, Myeloid - complications Leukemia, Myeloid - drug therapy Male Middle Aged Salvage Therapy Treatment Outcome |
| title | High‐dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: A case series |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T20%3A46%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%E2%80%90dose%20cyclophosphamide%20and%20etoposide%20for%20patients%20with%20refractory%20acute%20myeloid%20leukemia:%20A%20case%20series&rft.jtitle=American%20journal%20of%20hematology&rft.au=Talbot,%20Jeffrey&rft.date=2003-08&rft.volume=73&rft.issue=4&rft.spage=295&rft.epage=296&rft.pages=295-296&rft.issn=0361-8609&rft.eissn=1096-8652&rft_id=info:doi/10.1002/ajh.10362&rft_dat=%3Cwiley_cross%3EAJH10362%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12879438&rfr_iscdi=true |